| ADCORTYL/KENALOG | MHRA | 2007-8-1 | ADCORTYL/KENALOG-MHRA-2007-8-1 | MHRA has issued drug updates:
Gadolinium-containing contrast agents and nephrogenic systemic fibrosis
Extraneal and products that contain (or are metabolised to) maltose, xylose, or galactose: false glucose reading
a1-adrenoreceptor antagonists and intraoperative floppy iris syndrome
Cabergoline: risk of cardiovalvulopathy
Linezolid: restriction of indication
Dopamine agonists and pathological gambling, increased libido, and hypersexuality
Antidepressants and risk of suicidal behaviour
Isotretinoin for severe acne
Smoking-cessation aids |